Literature DB >> 26491810

Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.

Anand A Joshi1, Thomas F Murray2, Jane V Aldrich1.   

Abstract

The dynorphin (Dyn) A analogue zyklophin ([N-benzyl-Tyr(1)-cyclo(d-Asp(5),Dap(8))]dynorphin A(1-11)NH2) is a kappa opioid receptor (KOR)-selective antagonist in vitro, is active in vivo, and antagonizes KOR in the CNS after systemic administration. Hence, we synthesized zyklophin analogues to explore the structure-activity relationships of this peptide. The synthesis of selected analogues required modification to introduce the N-terminal amino acid due to poor solubility and/or to avoid epimerization of this residue. Among the N-terminal modifications, the N-phenethyl and N-cyclopropylmethyl substitutions resulted in analogues with the highest KOR affinities. Pharmacological results for the alanine-substituted analogues indicated that Phe(4) and Arg(6), but interestingly not the Tyr(1) phenol, are important for zyklophin's KOR affinity and that Arg(7) was important for KOR antagonist activity. In the GTPγS assay, while all of the cyclic analogues exhibited negligible KOR efficacy, the N-cyclopropylmethyl-Tyr(1) and N-benzyl-Phe(1) analogues were 28- and 11-fold more potent KOR antagonists, respectively, than zyklophin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491810      PMCID: PMC4771075          DOI: 10.1021/jm501827k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist.

Authors:  Marco A Bennett; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2002-12-19       Impact factor: 7.446

2.  Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.

Authors:  H Choi; T F Murray; G E DeLander; W K Schmidt; J V Aldrich
Journal:  J Med Chem       Date:  1997-08-15       Impact factor: 7.446

3.  N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.

Authors:  H Choi; T F Murray; G E DeLander; V Caldwell; J V Aldrich
Journal:  J Med Chem       Date:  1992-11-27       Impact factor: 7.446

4.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

5.  Automated allyl cleavage for continuous-flow synthesis of cyclic and branched peptides.

Authors:  S A Kates; S B Daniels; F Albericio
Journal:  Anal Biochem       Date:  1993-08-01       Impact factor: 3.365

6.  A solid-phase synthetic strategy for the preparation of peptide-based affinity labels: synthesis of dynorphin A analogs.

Authors:  L Leelasvatanakij; J V Aldrich
Journal:  J Pept Res       Date:  2000-08

7.  Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.

Authors:  S Arttamangkul; J E Ishmael; T F Murray; D K Grandy; G E DeLander; B L Kieffer; J V Aldrich
Journal:  J Med Chem       Date:  1997-04-11       Impact factor: 7.446

8.  Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.

Authors:  Stephen D Mague; Andrea M Pliakas; Mark S Todtenkopf; Hilarie C Tomasiewicz; Yan Zhang; William C Stevens; Robert M Jones; Philip S Portoghese; William A Carlezon
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

9.  Dynorphin-(1-13). I. Structure-function relationships of Ala-containing analogs.

Authors:  A Turcotte; J M Lalonde; S St-Pierre; S Lemaire
Journal:  Int J Pept Protein Res       Date:  1984-04

10.  Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.

Authors:  A M Kawasaki; R J Knapp; A Walton; W S Wire; T Zalewska; H I Yamamura; F Porreca; T F Burks; V J Hruby
Journal:  Int J Pept Protein Res       Date:  1993-11
View more
  5 in total

1.  Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).

Authors:  Wei-Jie Fang; Thomas F Murray; Jane V Aldrich
Journal:  Bioorg Med Chem       Date:  2017-11-21       Impact factor: 3.641

2.  Alanine scan of the opioid peptide dynorphin B amide.

Authors:  Anand A Joshi; Thomas F Murray; Jane V Aldrich
Journal:  Biopolymers       Date:  2017-09       Impact factor: 2.505

3.  Perfluoro-tert-butanol for selective on-resin detritylation: a mild alternative to traditionally used methods.

Authors:  Anita Wester; Anna Mette Hansen; Paul R Hansen; Henrik Franzyk
Journal:  Amino Acids       Date:  2021-08-19       Impact factor: 3.520

4.  In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist.

Authors:  Kristina Puls; Aina-Leonor Olivé-Marti; Szymon Pach; Birgit Pinter; Filippo Erli; Gerhard Wolber; Mariana Spetea
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-28

5.  Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.

Authors:  Yuanzi Zhao; Anand A Joshi; Jane V Aldrich; Thomas F Murray
Journal:  Biomed Pharmacother       Date:  2021-09-15       Impact factor: 6.529

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.